350996-89-3 Usage
Uses
Used in Pharmaceutical Development:
2-AMINO-4-ETHYL-5-METHYLTHIOPHENE-3-CARBOXAMIDE is utilized as a pharmaceutical precursor for the development of new drugs due to its potential medicinal properties. Its unique chemical structure allows it to be a key component in the synthesis of therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, 2-AMINO-4-ETHYL-5-METHYLTHIOPHENE-3-CARBOXAMIDE is used as a building block for the production of heterocyclic compounds. Its versatile structure makes it a valuable intermediate in the creation of complex organic molecules.
Used in Materials Science:
2-AMINO-4-ETHYL-5-METHYLTHIOPHENE-3-CARBOXAMIDE's distinctive structure also makes it a candidate for research and application in materials science, where it could potentially contribute to the development of new materials with unique properties.
Used in Research and Development:
2-AMINO-4-ETHYL-5-METHYLTHIOPHENE-3-CARBOXAMIDE is employed in research and development settings to explore its potential applications and to understand its chemical behavior, which could lead to innovative uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 350996-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,0,9,9 and 6 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 350996-89:
(8*3)+(7*5)+(6*0)+(5*9)+(4*9)+(3*6)+(2*8)+(1*9)=183
183 % 10 = 3
So 350996-89-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H12N2OS/c1-3-5-4(2)12-8(10)6(5)7(9)11/h3,10H2,1-2H3,(H2,9,11)
350996-89-3Relevant articles and documents
A novel series of positive modulators of the AMPA receptor: Discovery and structure based hit-to-lead studies
Jamieson, Craig,Basten, Stephanie,Campbell, Robert A.,Cumming, Iain A.,Gillen, Kevin J.,Gillespie, Jonathan,Kazemier, Bert,Kiczun, Michael,Lamont, Yvonne,Lyons, Amanda J.,MacLean, John K.F.,Moir, Elizabeth M.,Morrow, John A.,Papakosta, Marianthi,Rankovic, Zoran,Smith, Lynn
scheme or table, p. 5753 - 5756 (2010/12/18)
Starting from an HTS derived hit 1, application of biostructural data facilitated rapid optimization to lead 22, a novel AMPA receptor modulator. This is the first demonstration of how structure based drug design can be exploited in an optimization program for a glutamate receptor.
PYRAZOLEALKANAMIDE SUBSTITUTED THIOPHENES AS AMPA POTENTIATORS
-
Page/Page column 47, (2008/06/13)
The present invention relates to a heterocyclic derivative according to Formula (I) wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceuti